Aldeyra Therapeutics (NASDAQ:ALDX)

Aldeyra Therapeutics (NASDAQ:ALDX)

Share Price
$ 9.46
-0.03 (-0.32 %)
Market Cap
$248.27 m
Proactive Investors - Run By Investors For Investors

Aldeyra Therapeutics

Aldeyra Therapeutics, Inc. (Aldeyra), formerly Aldexa Therapeutics, Inc, is a biotechnology company. The Company is focused on the development of products to treat immune-mediated, inflammatory, orphan, and other diseases that are related to free aldehydes, a naturally occurring toxic chemical species.

52-week High/Low: $16.70 / $6.20
Sector: Pharmaceuticals
Market Cap: $248.27M
col 3
col 4
col 5
col 6

Aldeyra Therapeutics Timeline

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use